A Study to Assess Beta-Blocker Use in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction

Overview

About this study

The purpose of this study is to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Also to determine the association between beta-blocker use at discharge and cardiopulmonary outcomes in patients with COPD and AMI.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Willing and able to provide informed consent.
Men and women, age 35 or older.
Admitted to hospital from the Emergency Department or by hospital to hospital transfer with a primary diagnosis of AMI.
Undergo cardiac catheterization for AMI.
EMR-documented COPD

Exclusion Criteria:

Cognitive disorder that in the judgment of the investigator impairs understanding of the study objectives or assessments.
Vulnerable populations, including prisoners and pregnant women.

Eligibility last updated 9/14/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Megan Dulohery Scrodin, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Pulmonary Clinical Research Unit (800) 753-1606 PCRUE18@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Megan Dulohery Scrodin, M.D.

Closed-enrolling by invitation

Contact information:

Pulmonary Clinical Research Unit

(800) 753-1606

PCRUE18@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials